Clinical trial
Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)
NCT00119717 · CoAxia, Industry · Completed
Key facts
| NCT number | NCT00119717 |
|---|---|
| Title | Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) |
| Official title | Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) |
| Acronym | SENTIS |
| Lead sponsor | CoAxia, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident |
| Intervention type | Device, Other |
| Interventions | NeuroFlo™ catheter, Control |
| Enrollment | 515 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Jul 14, 2005 |
| Last update posted | May 18, 2011 |
| Countries | Austria, Belgium, Canada, Germany, Hungary, Israel, Puerto Rico, Spain, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: